Wedbush Assuming Coverage on Ardea Biosciences (RDEA) at Outperform, $37 Price Target
Tweet Send to a Friend
Wedbush is assuming coverage on shares of Ardea Biosciences (NASDAQ: RDEA) with an Outperform rating and $37 price target.
This article: 266 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 266 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
